Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
British Journal of Cancer|April 28, 2006
Targeting lymphangiogenesis to prevent tumour metastasisM G Achen, G B Mann, S A StackerInternational Journal of Experimental Pathology|April 8, 1999
The vascular endothelial growth factor family; proteins which guide the development of the vasculatureM G Achen, S A StackerCurrent Pharmaceutical Design|February 3, 2004
Molecular targeting of lymphatics for therapyS A Stacker, R A Hughes, M G AchenGrowth Factors (Chur, Switzerland)|January 1, 1997
Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic developmentM G Achen, J M Gad, S A Stacker, et al.Current Medicinal Chemistry|April 14, 2006
Current strategies for modulating lymphangiogenesis signalling pathways in human diseaseS A Stacker, R A Hughes, R A Williams, et al.The Journal of Biological Chemistry|September 28, 2001
Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysisM E Baldwin, S Roufail, M M Halford, et al.Proceedings of the National Academy of Sciences of the United States of America|January 22, 1998
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)M G Achen, M Jeltsch, E Kukk, et al.Molecular Medicine (Cambridge, Mass.)|January 10, 2002
VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiformeW Debinski, B Slagle-Webb, M G Achen, et al.The Journal of Biological Chemistry|November 27, 1999
A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeabilityS A Stacker, A Vitali, C Caesar, et al.Pageof 10